Press/Media
- 1 - 25 out of 132 results
Search results
-
Addition of Lenvatinib/Pembrolizumab to TACE in Unresectable Nonmetastatic HCC
24/01/25
1 item of Media coverage
Press/Media
-
-
LEAP-012 Data Support Triple Therapy in HCC— At Least for Progression-Free Survival
16/01/25
1 item of Media coverage
Press/Media
-
Immune Checkpoint Inhibitor-Based Systemic Therapy Combinations for Patients with HCC Amenable to TACE
15/01/25
1 item of Media coverage
Press/Media
-
-
Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
9/01/25
1 item of Media coverage
Press/Media
-
Mount Sinai: Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
9/01/25
1 item of Media coverage
Press/Media
-
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can't be treated with surgery
9/01/25
1 item of Media coverage
Press/Media
-
Global Trial Shows Major Boost in Liver Cancer Treatment Success
9/01/25
1 item of Media coverage
Press/Media
-
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery
9/01/25
1 item of Media coverage
Press/Media
-
Combination treatment for liver cancer significantly improves progression-free survival in global trial
9/01/25
1 item of Media coverage
Press/Media
-
An international study led by the Clínic improves liver cancer treatment
8/01/25
1 item of Media coverage
Press/Media
-
Lenvatinib-pembrolizumab plus TACE promising for intermediate-stage liver cancer
7/01/25
1 item of Media coverage
Press/Media
-
These are the 96 most cited Spanish researchers in the world, according to the Institute for Scientific Information in London.
25/11/24
1 item of Media coverage
Press/Media
-
La UB és la universitat de l’Estat amb més investigadors entre els més influents del món
21/11/24
1 item of Media coverage
Press/Media
-
Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics
19/11/24
1 item of Media coverage
Press/Media
-
Drug delays tumour growth in models of children's liver cancer
15/11/24
1 item of Media coverage
Press/Media
-
Reports from Universitat de Barcelona Add New Data to Research in Transforming Growth Factors (Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-b activation in HCC)
Barcena-Varela, M., Lindblad, K., Lujambio, A., Torres-Martin, M., Sia, D., Llovet, J., Thung, S. & Lujambio Goizueta, A.
8/11/24
1 item of Media coverage
Press/Media
-
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer
23/10/24
1 item of Media coverage
Press/Media
-
New drug, WNTinib, delays tumour growth and improves survival in mouse models of children’s liver cancer
21/10/24 → 23/10/24
4 items of Media coverage
Press/Media
-
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer
23/10/24
1 item of Media coverage
Press/Media
-
LEAP-012: Combination of Therapies Extends Progression-Free Survival in Intermediate-Stage Hepatocellular Carcinoma
7/10/24
1 item of Media coverage
Press/Media
-
Manel Esteller, recognized as Spain's most influential cancer researcher
25/09/24
1 item of Media coverage
Press/Media
-
Clínic-IDIBAPS researchers present around 40 studies at ESMO 2024
19/09/24
1 item of Media coverage
Press/Media